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Infertility affects an estimated 10% of couples, and in
roughly half of these cases the defect can be traced to
the man. Several groups have expressed the concern that
male-infertility rates may be on the rise in humans (Carl-
sen et al. 1992), as they are in many other species, pos-
sibly as a result of environmental toxins such as ana-
logues of sex hormones. Male infertility has also
attracted a great deal of recent attention from geneticists
and molecular and cell biologists, who have created tar-
geted disruptions of numerous testis-specific genes in the
mouse. Knockout technology has made that organism a
favored experimental model for studies of gametogenesis
(see Greenhouse et al. 1998 [this issue]); lessons from
the mouse seem, in many instances, to be applicable to
our species, and they may help to elucidate both intrinsic
and acquired male infertility. Physiological studies in the
mouse indicate that spermatogenesis and the later steps
in sperm maturation and activation are subject to com-
plex regulation, and they implicate these regulatory
events as possible causes of infertility in men.
The human Y chromosome has been the focus ofmuch
of the genetic analysis of male infertility. The smallest
of the 24 human chromosomes, the Y contains only 2%
of the haploid genome. Long before the cloning of genes
was possible, cytological studies had implicated the Y
chromosome in normal and abnormal male develop-
ment. More recently, 12 novel genes or families, 10 with
full-length cDNA sequences available, were identified by
a systematic search of the nonrecombining region (NRY)
of this chromosome (Lahn and Page 1997). Among the
genes in the NRY, the sex-determining gene on the Y
chromosome (SRY) is well known to be crucial for testis
formation. Microdeletions within the Y chromosome
have been observed in 6.4% of azoospermic or oligo-
spermic men (Gromoll et al. 1998). Analysis of these
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deletions demonstrates that at least three loci other than
SRY (the azoospermic-factor loci AZFa, AZFb, and
AZFc) are required for normal sperm development. Not
all of the relevant Y-chromosomal genes have been iden-
tified, but some candidate genes exist: RBM, for AZFb,
andDAZ (deleted in azoospermia) and SPGY, for AZFc.
Remarkably, all of these candidate genes, as well as the
homologous autosomal genes DAZLA and SPGYLA,
encode putative RNA-binding proteins that are ex-
pressed solely in the male gonad. A conserved role for
DAZ and DAZLA in spermatogenesis is suggested by
their homology with a Drosophila gene, boule, which is
required for male fertility in the fly (Chai et al. 1997).
Moreover, mice of either sex that have a homozygous
Dazla deletion are incapable of producing gametes, dem-
onstrating that Dazla is essential for the differentiation
of germ cells (Ruggiu et al. 1997). Many other genes
that are required in spermatogenesis are shown in table
1. An outstanding challenge remains—to understand the
relationship of these diverse genes to the developmental
events that begin with the establishment of the male
germ line and that end with the fusion of sperm to the
oocyte
Stages of Sperm Development and Maturation
The long journey of the sperm begins when the em-
bryonic primordial germ cells (PGCs), responding to sol-
uble stem-cell factor, migrate into the undifferentiated
gonad (Loveland and Schlatt 1997). PGCs then differ-
entiate into prospermatogonia and reside in a quiescent
state inside the testicular seminiferous tubules. Gonad-
otropic stimulation at the onset of puberty induces sper-
matogenesis (the meiotic divisions giving rise to the
sperm) followed by spermiogenesis (the differentiation
of the sperm cell, from haploid round spermatid to flag-
ellated sperm). Methylation of imprinted genes (see Bes-
tor 1998 [in this issue]) occurs between the spermato-
gonial and the spermatocyte stages. During the last stage
of spermiogenesis, the nucleus flattens and condenses,
as nonhistone basic proteins such as protamines displace
the typical histones that associate with nuclear DNA,
transcriptional activity in the spermatid is silenced, and
nucleosomal structure is lost (Eddy et al. 1993). At the
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same time, the remaining cytoplasm is jettisoned as a
“cytoplasmic droplet.” The resulting sperm then enter
the lumen of the tubule. Finally, sperm cells are exported
to the epididymis, where they are stored until they are
ejaculated from the male reproductive tract (Yanagi-
machi 1994). By the last stages of spermiogenesis, when
sperm are released into the lumen of the tubule, their
ribosomes are nearly absent, and their endoplasmic re-
ticulum (ER) has been lost from the cytoplasm (Cler-
mont and Rambourg 1978). Because they have no ma-
chinery to produce proteins, all of the factors that sperm
will require for ascending the female reproductive tract
either must be synthesized in advance and stored ormust
be provided from the outside—for example, by the cells
of the cauda epididymis.
Sperm morphogenesis is accomplished inside the tes-
tis, but testicular sperm remain physiologically “im-
mature.” During transit, mammalian sperm undergo ep-
ididymal maturation, but they remain unable to fertilize
oocytes. The final preparatory step, capacitation, occurs
only when sperm have resided in the female genital tract
for some time. This ill-defined process appears to be
necessary for sperm to undergo a further morphological
and physiological transition, the acrosome reaction,
once they encounter the zona pellucida (ZP) of the egg.
The acrosome, a caplike structure covering the anterior
portion of the sperm nucleus, contains multiple hydro-
lytic enzymes that are released by exocytosis prior to
fertilization. Simultaneously, extensive changes occur in
all sperm compartments (head and flagellum,membrane,
cytosol, and cytoskeleton). Factors originating from ep-
ididymal fluid and seminal plasma are lost or redistrib-
uted, membrane lipids and proteins are reorganized, and
complex signal-transduction mechanisms are initiated
(Yanagimachi 1994).
With the advent of intracytoplasmic sperm injection
(ICSI) in the treatment of infertility, it has become clear
that the various postmeiotic steps in spermatogene-
sis—which are clearly required for sperm to reach the
oocyte and to cross the oolemma in vivo—are irrelevant
to human zygote formation per se. With ICSI, primary
spermatocytes, “immature” testicular sperm, and even
intentionally damaged samples, containing only physi-
ologically dead sperm, all appear to be “fertile” in mice
(Wakayama et al. 1998).
Functional Equivalence among Sperm
Fundamental to Mendelian genetic analysis is the as-
sumption that gametes have an equal chance of con-
tributing their haploid genomes to a zygote, whatever
alleles they carry. Sperm, of course, are far from being
genetically homogeneous, so their functional equivalence
is not obvious. Indeed, transmission distortion has been
clearly documented in the mouse, particularly in studies
of the t-complex on the proximal third of mouse chro-
mosome 17. Certain t-haplotypes contribute to defective
sperm function in fertilization. Males carrying two t-
haplotypes (tx/ty mice) are sterile; their sperm have very
poor motility and are unable to fertilize eggs. However,
males carrying one t-haplotype (t/) are fertile, and the
sperm carrying the t-haplotype are preferentially trans-
mitted to the pups (Johnson et al. 1995). Transmission
distortion has also been suggested in a variety of human
traits, but the published evidence in most such cases is
not conclusive (however, for an example of human trans-
mission distortion carried through the female, see Nau-
mova et al. 1998 [in this issue]). It appears that the
assumption of functional equivalence, though not uni-
versally valid, is nevertheless generally correct in both
mice and humans.
Two developmental mechanisms have come to light
that may preserve this equivalence. First, proteins and
mRNA are synthesized in premeiotic germ cells and are
distributed among developing spermatids. This suggests
that much of the regulation of later events in sperm
maturation must act at the posttranscriptional and post-
translational levels, as is indeed the case (see below).
Second, haploid spermatids share mRNA and proteins
through cytoplasmic bridges that persist after meiosis
until the late stages of spermiogenesis. Transgenic ani-
mals that synthesize the human growth hormone exclu-
sively in postmeiotic germ cells distribute this gene prod-
uct to all of their sperm, even when the transgene is
present only at a single locus in the diploid genome
(Braun et al. 1989). Moreover, the product of the X-
linked Akap82 gene, which is expressed postmeiotically
and which is required for the organization of the sperm
tail, is found in all spermatids, again indicating sharing
of cytoplasmic contents (Moss et al. 1997). Thus, there
is no doubt that, in their differentiation, sperm make
use of the products of both sets of parental chromo-
somes. Still uncertain is the relative importance, in hu-
man spermiogenesis, of premeiotic synthesis and of post-
meiotic sharing of cytoplasmic contents.
Regulation of Gene Expression in the Testis
Many proteins are required uniquely in spermatogen-
esis, and, as in most systems, much of the tissue-specific
regulation in the testis is accomplished at the transcrip-
tional level. Testis-specific promoters have been de-
scribed for a number of such genes, including those for
protamine-1 and -2, transition protein-1 and -2 (Tp1
and Tp2), mitochondrial-capsule selenoprotein, acrosin,
and calmegin (Watanabe et al. 1995). Certain genes that
are expressed in the soma as well as in the gonad are
transcribed from promoters that are inactive outside the
testis. Thus, a form of the angiotensin-converting en-
zyme (ACE) that is expressed only in postmeiotic sper-
Table 1
Targeted Disruption of Mouse Genes Related to Male Infertility
Gene Name
Wild-Type Expression
Pattern
Phenotype in
Spermatogenesis Other Effects Reference(s)
A-myb (myb family of
nuclear se-
quence–specific
DNA-binding
proteins)
Predominantly in male
germ cells and in fe-
male breast ductal
epithelium
Blocked at pachytene
stage
Impaired mammary-
gland development
Toscani et al. (1997)
Ace Somatic ACE in vascu-
lar endothelial cells
and several epithelia,
testicular ACE in
spermatids
Inefficient sperm ascen-
dancy of oviduct, im-
paired binding of ZP-
binding ability
Low blood pressure Krege et al. (1995)
Atm (mutated in
ataxia-telangiectasia)
Nearly ubiquitous, high
in spleen, thymus,
testis
Blocked at zygotene/
pachytene stage
Growth retardation,
immune defects, lack
of primary oocytes in
female
Xu et al. (1996)
Acrosin (sperm acroso-
mal enzyme)
Spermatid, low levels at
pachytene stage
Fertile Normal Baba et al. (1994)
Bax (apoptotic regula-
tor [partner of
BCL2])
Transcribed in wide va-
riety of cells from
early embryogenesis
Blocked at round-sper-
matid stage, accumu-
lation of atypical
premeiotic germ cells
Atretic follicles with ex-
cess granulosa cells,
hyperplasia of thy-
mocytes and B cells
Knudson et al. (1995)
Bmp-8B (bone morpho-
genetic protein 8B)
Testis, prominent in
stage 6–8 round
spermatids
Small testes, decreased
spermatogonia, in-
creased apoptosis in
germ cells
Normal Zhao et al. (1996)
Crem Premeiotic germ cells,
CREM-t in pachy-
tene spermatocytes
Blocked at round-sper-
matid stage
Normal Blendy et al. (1996);
Nantel et al. (1996)
Calmegin Spermatocyte to round
spermatid stages
Normal-looking but in-
fertile sperm, im-
paired binding of ZP
Normal Ikawa et al. (1997)
Dazla (cytosolic RNA-
binding protein)
Expressed exclusively in
gametogenic cells
No germ cells beyond
spermatogonial stage
No eggs in follicles in
female
Ruggiu et al. (1997)
Estrogen receptor Hypothalamus, anterior
pituitary gland, re-
productive organs
Dilated seminiferous tu-
bules, disrupted
spermatogenesis
Decreased sexual recep-
tivity in female
Eddy et al. (1996)
GalTase (galactosyl
transferase)
Sperm surface, also
highly expressed in
mammary, low ex-
pression in neurons
Fertile Normal Asano et al. (1997)
Hr6b (ubiquitin-conju-
gating DNA-repair
enzyme)
Ubiquitous Blocked at elongating-
spermatid stage
Normal Roest et al. (1996)
Hsp70.2 (heat-shock
protein)
Spermatocyte Blocked at pachytene
stage
Normal Dix et al. (1997)
Igf1 (insulin-like
growth factor-1)
Mainly in liver, testicu-
lar-expression varia-
tion (depending on
species)
Small testes, sterile in
vivo but fertile in
vivo
Limited growth (∼30%
of normal size); in fe-
male, no ovulation,
hypoplastic
myometrium
Baker et al. (1996)
Mlh1 (DNA mis-
match–repair
enzyme)
Virtually ubiquitous Blocked in pachytene
stage
Prone to tumors, fe-
male infertility with
reduced numbers of
oocytes
Edelmann et al. (1996)
Nhlh2 (basic helix-
loop-helix transcrip-
tion factor)
Specific regions of de-
veloping CNS and
peripheral nervous
system
Few or no spermatids Fourfold reduction of
FSH level, obesity, fe-
male infertility with
reduced numbers of
oocytes
Good et al. (1997)
(continued)
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Table 1 (continued)
Gene Name
Wild-Type Expression
Pattern
Phenotype in
Spermatogenesis Other Effects Reference(s)
Pc4 Spermatocytes and
round spermatids
Normal-looking but in-
fertile sperm, low
fertility in vivo
Normal Mbikay et al. (1997)
Pms2 (postmeiotic
segregation)
Ubiquitous Infertile with morpho-
logically abnormal
sperm
Prone to sarcomas and
lymphomas
Baker et al. (1995)
Prolactin receptor Virtually ubiquitous Infertility in 20% of
males
Impaired mammary-
gland development in
female, reduced ovu-
lation, implantation
failure
Chappell et al. (1997)
RARa (retinoic acid re-
ceptor-a)
Ubiquitous No spermatogenic cells
in most tubules
Normal Lufkin et al. (1993)
RARg (retinoic acid re-
ceptor-g)
Presomitic caudal re-
gion and fronto-nasal
mesenchyme at 8.0
dpc, also in adult
skin
Sterile squamous meta-
plasia of seminal ves-
icles and prostate
Growth deficiency, in-
creased mortality
Lohnes et al. (1993)
c-Ros Various epithelial-cell
types
Infertile in vivo, fertile
in vitro
Normal Sonnenberg-Rieth-
macher et al. (1996)
RXRb (retinoic acid re-
ceptor-b)
Transcribed in many
tissues, Sertoli cells in
testis
Faulty lipid metabolism
in Sertoli cells, oligo-
astheno-
teratozoospermia
Embryonic and perina-
tal death of fraction
of / mice
Kastner et al. (1996)
Telomerase Active in germ cells
and in highly prolif-
erative stem cells
Absence of spermato-
genic cells in 6th
generation of /
mice
Compromised hemato-
poietic proliferation,
female sterility in 6th
generation of /
mice
Lee et al. (1998)
Zfx (zinc-finger
protein)
Virtually ubiquitous 50% reduction in
sperm counts
Small size, loss of via-
bility, low female fer-
tility, few oocytes
Luoh et al. (1997)
matogenic cells and sperm is transcribed from a pro-
moter that is located within intron 12 of the somatic
ACE gene. The proper cell- and stage-specific expression
of this testis-specific ACE requires only a small portion
of the immediate upstream, including a cyclic AMP-re-
sponsive element (CRE [Howard et al. 1993]). In Sertoli
cells, a unique testicular form of the hematopoietic tran-
scription factor GATA-1 is expressed from a promoter
located 5′ to the first erythroid exon, and the remaining
exons are used in common by both testis and erythroid
transcripts. This promoter allows GATA-1 to act as a
developmental stage– and spermatogenic cycle–specific
transcriptional regulator in Sertoli cells (Yomogida et al.
1994).
Alternative splicing may also take place in the testis,
to generate unique male germ-line–specific isoforms of
common proteins. Human CD46, a transmembrane pro-
tein that acts in somatic tissues to inactivate comple-
ment, is alternatively spliced in the testis. The spermatid
isoform of CD46 localizes not to the plasma membrane
but to the acrosomal membrane. CD46 is exposed to
the sperm’s extracellular environment only after the ac-
rosome reaction, and it may participate in sperm/egg
recognition (Anderson et al. 1993; Seya et al. 1993).
Likewise, the Crem (CRE modulator) gene generates a
large family of transcripts by alternative splicing and
alternative promoter usage. These transcripts encode a
variety of activating and inhibitory transcriptional reg-
ulators. CREM-t is expressed in premeiotic germ cells
in low amounts and in the antagonist form, but, from
the pachytene-spermatocyte stage onward, the splicing
pattern of this transcript changes, and the CREM-t ac-
tivator accumulates in extremely high amounts (Foulkes
et al. 1992). Various target genes that are expressed in
postmeiotic germ cells are reported to be transcription-
ally activated by CREM-t. Germ cells from CREM-de-
ficient mice arrest postmeiotically at the first step of sper-
miogenesis, and they undergo apoptosis at a significantly
increased rate; these animals lack any late spermatids,
and their expression of mRNAs for protamine-1 and
-2, Tp-1 and -2, and other sperm proteins is dramatically
reduced (Blendy et al. 1996; Nantel et al. 1996).
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Protamine-1 is also an example of a large class of
genes that undergo translational regulation in the male
germ line. The protamine-1 mRNA is first transcribed
postmeiotically in round spermatids, but it is stored in
an untranslatable form as a ribonucleoprotein particle
for as long as 1 wk before it is translated. It is proposed
that sequence-specific RNA-binding proteins interact
with the protamine 3′ UTRs and mediate the temporal
control of protamine expression (Fajardo et al. 1994).
The use of RNA-binding proteins may be a common
feature of the developmental regulation of long-lived
mRNA (Wu et al. 1997).
Posttranslational Control of Spermatid-Membrane
Proteins
Various proteins have been proposed as candidate ad-
hesion molecules on sperm. These include sp56, PH-20,
zonadhesin, p95, and sp17 (implicated in the sperm/ZP
interaction) and fertilin, cyritestin, and CD46 (in the
sperm/egg plasma-membrane interaction). Despite the
large number of these proteins, there is little reason to
suspect functional redundancy among these receptors.
Indeed, antibody-blocking experiments indicate that
most or all of these molecules are essential for fertility,
possibly indicating functional interactions between these
molecules. Another kind of functional interaction may
occur between these molecules and the biosynthetic ma-
chinery that produces them, and targeted gene disrup-
tions suggest that these interactions may also be required
for fertility.
As in other tissues, newly synthesized membrane pro-
teins in the germ line emerge through the ER membrane
and undergo folding and glycosylation. These events are
mediated by resident ER chaperones and modifying en-
zymes, which also perform “quality control,” recogniz-
ing and retaining proteins that are not in their final
folded conformation. Evidence is accumulating that
many disease-causing mutations and modifications exert
their effects by alteration of protein folding (for reviews,
see Thomas et al. 1995; Ashkenas and Byers 1997). In-
teractions between nascent proteins and ER chaperones
also appear to be crucial for the later stages of sperm
maturation.
The soluble ER-chaperone protein calreticulin is re-
markable for its effects on cellular adhesion in fibroblasts
and other cell types. Calreticulin associates with the cy-
toplasmic domains of integrin alpha-subunits, and this
interaction influences integrin-mediated cell adhesion to
the extracellular matrix. Embryonic fibroblasts from cal-
reticulin-deficient mice are severely impaired in integrin-
mediated adhesion, despite the fact that the expression
of integrins on the surface of these cells is unaffected.
Expression of recombinant calreticulin cDNA in ho-
mozygous knockout ES cells rescues integrin-mediated
adhesion. Coppolino et al. (1997) have demonstrated
that calreticulin is an essential modulator both of inte-
grin adhesive functions and of integrin-initiated signal-
ing. It is not known whether calreticulin plays a similar
role in modulating the adhesion of sperm to oocytes,
but this chaperone is expressed in the acrosome and in
the Golgi apparatus of mature sperm. Because calreti-
culin is an essential gene, calreticulin-deficient sperm are
not available. Nonetheless, the principal that transient
interactions with chaperones can alter the function of
adhesive receptors seems to apply to sperm maturation,
as suggested by the phenotype of another targeted mu-
tation in the mouse.
Calnexin is a ubiquitous ER chaperone that plays a
major role in quality control, by retaining incompletely
folded or misfolded proteins. Unlike several other ER
chaperones, such as BiP and calreticulin, calnexin is an
integral membrane protein. Calmegin is a testis-specific
ER protein that is homologous to calnexin. We have
shown that calmegin binds to nascent polypeptides dur-
ing spermatogenesis, and, by targeted disruption of its
gene, we have analyzed its physiological function. Ho-
mozygous-null male mice are nearly sterile, even though
spermatogenesis is morphologically normal and mating
is normal. In vitro, sperm from homozygous-null males
do not adhere to the egg extracellular matrix, the ZP
(see Greenhouse et al. 1998 [in this issue]), and this
defect may explain the observed infertility (Ikawa et al.
1997). Analysis of two-dimensional gels of sperm sur-
face or total proteins indicates that sperm fromCalmegin
/ mice is indistinguishable from wild-type sperm.We
have further examined the surface expression of most of
the candidate proteins, for evidence of mediation of
sperm-egg interaction, using immunostaining or flow cy-
tometry, and we have yet to detect a quantitative or
qualitative difference between mutant and wild-type
sperm. This may indicate, by analogy with the Calreti-
culin-mutant mouse, that calmegin is required for sperm
proteins to attain their normal conformations or to form
essential quaternary interactions. To confirm the phe-
notype of the calmegin disruption, we examinedwhether
the infertility of the knockout mice could be rescued by
expression of a calmegin transgene. Among transgenic
mouse lines, only those that expressed the transgene re-
gained their fertilizing ability (M. Ikawa and M. Okabe,
unpublished data). Transgenic mice that express either
calmegin or a calmegin-calnexin chimeric protein may
provide crucial insights into interactions between sperm
surface proteins and ER chaperones.
Targeted Disruption of Genes Expressed in the Testis
A large number of genes that are known to be ex-
pressed in the testis or in maturing spermatocytes have
been disrupted in the mouse, to test their function in
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male fertility. Surprises in this field have been numerous,
as the following examples show.
Proteinases: Acrosin and Fertilin
Acrosin is a stored serine proteinase that is released
from sperm in the acrosome reaction. Acrosin, produced
from an inactive precursor, pro-acrosin, by proteolytic
clipping, is the major such secreted proteinase, and it
has been predicted to play a key role in fertilization, by
degrading the ZP locally to permit access of sperm to
the egg surface. However, male mice homozygous for a
targeted mutation in the Acrosin gene are fertile, despite
a complete lack of acrosin activity in their sperm (Baba
et al. 1994). This unexpected phenotype may indicate
that other sperm-derived proteinases are sufficient to de-
grade the ZP.
Fertilin is a heterodimeric sperm plasma-membrane
protein. Both of its subunits belong to the MDC (me-
talloproteinase-like, disintegrin-like, cysteine-rich) fam-
ily of surface proteins, which contain a metalloprotease
and a disintegrin domain. The disintegrin domain of
fertilin-b has been reported to mediate binding to the
egg cell surface, whereas a “fusion peptide” derived from
the a subunit is believed to participate in the fusion of
the two gametes. Mice deficient in the fertilin-b gene
produce morphologically normal sperm with impaired
binding to the ZP, as well as binding ability to eggs (C.
Cho, personal communication).
Peptide-Processing enzymes: ACE and PC4
ACE is a membrane-bound dipeptidyl carboxy-pep-
tidase that generates the vasoconstricting peptide angi-
otensin II and that inactivates the vasodilating peptide
bradykinin. The gene encoding ACE consists of two ho-
mologous regions and encodes both a somatic- and a
testis-specific isoenzyme. Female mice deficient for both
forms of ACE were found to be fertile, but the fertility
of homozygous male mutants was greatly reduced
(Krege et al. 1995). The cause of the male sterility was
demonstrated to be a defect in sperm migration within
the oviducts, as well as a decreased ability to bind to
the ZP. This phenotype in the male was not an indirect
effect of a blood-pressure decrease caused by the loss of
somatic ACE expression: mutant males that lack only
the somatic form of ACE were found to be fertile. The
male-specific infertility of animals lacking the testis-spe-
cific ACE is curious, because angiotensin itself does not
seem to be required for spermatogenesis. Indeed, male
mice lacking angiotensinogen are reported to have nor-
mal fertility (Tanimoto et al. 1994). No other substrate
of ACE in the testis has been proposed.
PC4 is a member of the proprotein convertase (PC)
family of serine proteases, which are implicated in the
processing of a variety of prohormones, proneuropep-
tides, and cell-surface proteins. In rodents, PC4 tran-
scripts have been detected in spermatocytes and round
spermatids exclusively, suggesting a reproductive func-
tion for this enzyme. As expected, the in vivo fertility of
homozygous mutant males was severely impaired, but
no spermatogenic abnormality was evident. In vitro, the
fertilizing ability of PC4-null spermatozoa was also sig-
nificantly reduced (average litter size 6.9, comparedwith
0.8 in wild-type and / mice). Interestingly, if the av-
erage litter size is calculated only on the basis of suc-
cessful matings, the figure increases to 3.3 in knockout
mice. Calmegin-deficient mice are similar in this regard.
Their average litter size is 0.02, compared with 8.2 in
wild-type mice, but one successful mating resulted in 2
pups. This indicates that, in some females (or in some
ejaculates), the defect in fertility is not as severe as the
average value would suggest. Anecdotal evidence sug-
gests that this pattern may occur in humans as well.
Many supposedly infertile couples find, to their surprise,
that they are suddenly able to conceive.
A Signaling Molecule: c-ros
c-ros is a receptor-type tyrosine kinase that is ex-
pressed in a small number of epithelial-cell types, in-
cluding those of the caput epididymis. Targeted muta-
tions of c-ros cause male but not female infertility. Sperm
isolated from c-ros / mice appear normal and can
fertilize eggs efficiently in vitro. Remarkably, sperm de-
rived from c-ros / spermatocytes have their in vivo
fertilization capacity restored if they pass through the
wild-type epididymal epithelium of a chimeric mouse
(Sonnenberg-Riethmacher et al. 1996). Thus, whereas
spermatogenesis does not appear to be affected in c-
ros–deficient mice, sperm maturation is impaired, be-
cause of a defect in a signaling pathway in epididymal
cells. It has been suggested that glycosylphosphatidyli-
nositol-anchored proteins are transferred to the sperm
surface during epididymal transit (Kirchhoff et al. 1997),
and it may be that c-ros is required for such transfer.
However c-ros may act in this tissue, the infertility of
these sperm seems to be explained by their failure to
reach the oviduct, despite the fact that they are produced
in normal numbers. This phenotype is reminiscent of
that of Ace knockout animals, and it may indicate a
failure of some form of “homing” mechanism in both
classes of mutants.
Prospects for the Future
It is clear that a man can be diagnosed as infertile if
he is azoospermic or oligospermic. However, there are
many infertile men who have semen parameters within
the normal range but who show diminished binding of
sperm to the ZP; still others may be deficient either at
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one or more of the later steps of sperm maturation or
in the expression or activation of stored sperm com-
ponents. The sheer diversity of mouse mutations that
cause male infertility may be daunting, but work in this
system now provides a number of candidate genes that
may be relevant to infertility in men. The prediction of
men’s fertility on the basis of their genotype could be
possible in the future, but a more immediate application
of this knowledge is likely to occur in the design of novel
forms of contraception. For each of the many genes that
are required for the development of active sperm (table
1), there may be one or more treatments developed that
can mimic the observed effects of mutations on sperm
synthesis or function.
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